1,894 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.
Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.
Intuitive Surgical recalled 219 da Vinci surgical systems on November 7, 2025, due to a software error. This error allowed malfunctioning instrument arms to remain in clinical use, posing a high risk of failure. Healthcare providers and patients must stop using these systems immediately.
C.R. Bard recalled 116 units of its InLay Optima Ureteral Stent Kit on November 6, 2025. A labeling discrepancy may cause the actual stent size to differ from the labeled size. Healthcare providers and patients should stop using the device immediately.
C.R. Bard Inc recalled 116 units of the InLay Optima Ureteral Stent Kit on November 6, 2025. The recall stems from a labeling discrepancy where the actual stent size may not match the product label. This recall affects distribution in multiple U.S. states and several countries worldwide.
Bard Peripheral Vascular recalled 1,240 Safe-T-Centesis Catheter Drainage Trays due to safety indicator defects. The recall affects products distributed nationwide since November 6, 2025. The defect may cause serious injuries during use in medical procedures.
The recall involves Neaude BR0221SL001 adult portable bed rails sold on Amazon. It poses a serious entrapment and asphyxiation risk. Consumers should stop using the recalled rails and start the refund process with Neaude now.
CareFusion 303 recalled 189 BD Alaris Pump Modules on November 6, 2025. The recall affects connectivity to hospital networks due to daylight savings time adjustments. Users should stop using the device immediately and follow manufacturer instructions.
C.R. Bard recalled 116 units of its InLay Optima Ureteral Stent Kit on November 6, 2025. A labeling discrepancy may cause the actual size of the stent to differ from what is indicated on the label. The recall affects distribution across the U.S. and several countries worldwide.
C.R. Bard recalled 4,350 units of the InLay Optima Ureteral Stent Kit on November 6, 2025. The recall was initiated due to a labeling discrepancy where the actual size of the stent may not match its label. This affects distribution across the U.S. and several countries worldwide.
Fresenius Kabi USA, LLC recalls 2,199,850 vials of Famotidine Injection, U.S. distribution nationwide plus Alaska, Hawaii and Puerto Rico after endotoxin testing concerns. The microbial contamination risk prompted an immediate stop-use order. Healthcare providers and patients should follow recall guidance and seek alternatives through their providers.
Diasol recalled 4,400 gallons of its dialysis liquid concentrate on November 5, 2025. The recall follows concerns that the safety and efficacy of the product cannot be assured. Healthcare providers and patients should stop using the product immediately.
Diasol recalled 7,200 gallons of its 100125-10-DEX100 liquid concentrate on November 5, 2025. The recall affects dialysis patients in multiple states due to unassured safety and efficacy. Patients and healthcare providers must stop using this product immediately.
Lupin Pharmaceuticals recalled 52,128 bottles of Sertraline Hydrochloride Tablets on November 5, 2025. Consumers reported issues with defective seals that do not adhere to the bottles. The recall follows a Class II classification due to potential contamination risks.
Diasol recalled 2,200 gallons of its 100425-10-DEX100 liquid concentrate for bicarbonate dialysis on November 5, 2025. The company cannot assure the safety and efficacy of the product. Patients and healthcare providers should stop using it immediately.
Cepheid recalled 9,880 units of Xpert MTB/RIF GXMTB/RIF-US-10 after testing failed to meet stability criteria. The devices were distributed nationwide in the United States and Puerto Rico. Health care providers and patients should stop using the device immediately and follow the recall instructions.
Diasol recalled 74,400 gallons of its Liquid Concentrate for Bicarbonate Dialysis on November 5, 2025. The recall stems from concerns about the safety and efficacy of the dialysis acid concentrate. Patients and healthcare providers should stop using the product immediately.
Diasol recalled 4,400 gallons of its 100230-10-DEX100 dialysis acid concentrate on November 5, 2025. The company cannot assure the safety and efficacy of this product. Healthcare providers and patients must stop using the concentrate immediately.
Diasol recalled 186,000 containers of its liquid concentrate for bicarbonate dialysis on November 5, 2025. The company cannot assure the safety and efficacy of the product. Patients and healthcare providers should stop using it immediately and follow recall instructions.
Datascope recalled 11,470 Intra-Aortic Balloon Pump systems on November 4, 2025. The recall addresses a revision in the Preventative Maintenance schedule as outlined in the Service Manual. Healthcare providers and patients must stop using these devices immediately.
Datascope recalled 47 units of its Cardiosave Rescue Intra-Aortic Balloon Pump on November 4, 2025. The recall addresses a revised Preventative Maintenance schedule in the device's instructions for use. This issue poses a high risk to patient safety and requires immediate attention from healthcare providers.
GET TESTED INTERNATIONAL AB recalled 3 units of the Biological Age & Longevity Test distributed nationwide in the United States. The recall concerns distribution without premarket approval or clearance. Consumers should stop using the device and follow the manufacturer's instructions. Contact GET TESTED INTERNATIONAL AB for guidance.
GET TESTED INTERNATIONAL AB recalled 4 Organic acids Test kits distributed nationwide in the United States. The devices were distributed without FDA premarket approval or clearance. Patients and healthcare providers should stop using the device immediately and follow recall instructions.
GET TESTED INTERNATIONAL AB recalled 17 units of its Adrenal Test on November 3, 2025. The recall occurred due to distribution without premarket approval or clearance. Patients and healthcare providers must stop using the device immediately.
GET TESTED INTERNATIONAL AB recalled 4 MPOX Test devices distributed nationwide in the United States after distribution without premarket approval. The recall cites a regulatory violation rather than an injury risk. Healthcare providers and patients should stop using the device immediately and await instructions from the manufacturer.
Get Tested International AB recalled 1,361 HSV-1 and HSV-2 Test Kits distributed nationwide in the United States after regulators found distribution without premarket approval. The test kit lacks FDA premarket approval or clearance. Patients and healthcare providers should stop using the device immediately and follow the manufacturer's recall instructions by contacting Get Tested International AB.
Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.